In our previous study, we discovered that TFPI2 was downregulated in hyperglycaemia-stimulated VSMCs, in which PARP1 activation plays a key role in promoting DNA methylation of the TFPI2 promoter and TFPI2 downregulation [17]. The gene discussed is PARP1; the disease is Hyperglycemia.